Search
for
Sort by
Research 30 of 1000+
- Paraneoplastic alopecia associated with internal malignancies in the cat
- The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies.
- Alopecia Areata and malignancies: uncertainties clarified by a large-scale population-based study
- Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors
- Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases
- Risk of Estrogen-Driven Malignancies in Females on 5-alpha Reductase Inhibitors
- Platelet‐Rich Plasma Injections and Scalp Cutaneous Malignancies: Clinical Implications and Knowledge Gaps
- Provenge is Talk of GU Malignancies Congress
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- New insights into the functions of Cox-2 in skin and esophageal malignancies
- The impact of patient-dependent risk factors on morbidity and mortality following gastric surgery for malignancies
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Postzygotic KRAS G12C mutation, associated with various malignancies, is also underling epidermal nevus syndrome
- Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
- How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Male fertility and skin diseases
- Alopecia as a systemic disease
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Cutaneous Sequelae After Burn Injury: Pruritus, Dyspigmentation and Malignancy—Mechanisms and Management
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program